Vectorite Biomedical Inc. (TPEX:4170)
Taiwan · Delayed Price · Currency is TWD 12.00
0.00 (0.00%)
Oct 30, 2026, 9:00 AM CST
Vectorite Biomedical Market Cap
Vectorite Biomedical has a market cap or net worth of 525.25 million as of October 30, 2026. It is the 37,781st most valuable company in the world and the 2,240th biggest in Taiwan. Its market cap has decreased by 14.59% in one year.
Market Cap
525.25M
Enterprise Value
-68.84M
Revenue
54.81M
Global Rank
Country Rank
#2,240 Taiwan
PE Ratio
4.47
ChartMarket Cap Chart
Since April 15, 2013, Vectorite Biomedical's market cap has increased from 393.23M to 525.25M, an increase of 33.57%. That is a compound annual growth rate of 2.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 525.25M | -14.29% |
| Dec 31, 2025 | 612.80M | -3.45% |
| Dec 31, 2024 | 634.68M | -32.08% |
| Dec 29, 2023 | 934.52M | 49.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enimmune | 918.00M |
| MegaPro Biomedical | 909.33M |
| Meribank Biotech | 827.31M |
| Lukas Biomedical | 774.68M |
| NatureWise Biotech & Medicals | 736.54M |
| BioLASCO Taiwan | 726.10M |
| Neith | 701.87M |
| Taiwan Advance Bio-Pharmaceutical | 625.50M |